S&P 500
2013.66
+2.30 +0.11%
Dow Indu
17304.43
+38.44 +0.22%
Nasdaq
4591.34
-2.09 -0.05%
Crude Oil
91.47
-0.51 -0.55%
Gold
1219.630
-0.005 -0.00%
Euro
1.284075
-0.005680 -0.44%
US Dollar
84.677
+0.387 +0.50%
Weak

5 YEAR US INT RATE SWAP Mar 2013 (E) Future

Chicago Board of Trade › 5 YEAR US INT RATE SWAP Mar 2013 (E) (CBOT:SA.H13.E)

114.781250 +0.109375 (+0.10%)

2013-03-18 17:15:16, 10 min delay

5 YEAR US INT RATE SWAP Mar 2013 (E) (CBOT:SA.H13.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price114.781250
Settle Time17:15
Previous Close114.750000
Low114.578125
Time2013-03-18 17:15:16
Contract High Date2012-12-06
Contract Low Date2013-01-30
Open Time18:00
Net Change0.109375
Open114.578125
High114.640625
Open Int.2942
Contract High115.59375
Contract Low114.0625
Expiration2013-03-18
Close Time17:00

Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for 5 YEAR US INT RATE SWAP Mar 2013 (E) (SA.H13.E) now.

Symbol
First Name
Last Name
Email
 

By filling out the form, you'll receive access to trend analysis, educational videos, and other trading resources from INO.com. Trend Analysis will be sent directly to your inbox.


Trader's Blog

Poll: Will you buy Alibaba stock?
   2 hours, 12 minutes ago
A Peek Inside 3 Billionaires' Portfolios
   21 hours ago
How to Pick Intraday Market Direction - The 80% Rule
   1 day ago

Today's Financial News

White House orders government to create national plan on antibiotic-resistant bacteria by 2015

4 hours ago

WASHINGTON (AP) — Signaling the seriousness of the threat posed by antibiotic-resistant germs, President Barack Obama on Thursday ordered the government to create a national plan to fight them by early 2015. Already the world is facing a situation where once-treatable germs can kill. Repeated exposure to antibiotics can lead germs to become resistant to the drug so that it is no longer effective in treating a particular illness.

CBS-owned TV Guide Network rebranding itself as pop culture destination

4 hours ago

NEW YORK (AP) — The TV Guide Network is rebranding itself as POP, promising to make itself a destination for hard-core pop culture fans. The network, owned by the CBS Corp. and Lionsgate, is currently in 80 million homes. Owners said Thursday the switch is planned for early next year. Owners promise one series that follows dedicated fans of New Kids on the Block and another called "The Story Behind," with stories about how some of television's biggest hits got their start. POP will also continue the TV Guide Network's red carpet coverage of various awards shows.

China fines British drug maker GlaxoSmithKline $492 million for bribery, orders exec deported

4 hours ago

BEIJING (AP) — Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China in the biggest such penalty ever imposed by a Chinese court. The case, first publicized in mid-2013, highlighted the widespread use of payments to doctors and hospitals by sellers of drugs and medical equipment in a poorly funded health system that Chinese leaders have promised to improve. The fine is the largest such penalty ever imposed by a Chinese court.

GM to introduce new, high-end Cadillac next year, start production at Detroit plant

4 hours ago

DETROIT (AP) — General Motors will begin building a new, top-end Cadillac sedan late next year at its Detroit-Hamtramck assembly plant. The auto maker said Friday that the rear-wheel drive car will make its debut in the first half of 2015, and that it will reveal the name of the new model soon. The new Cadillac is part of a $384 million investment GM announced last spring in the assembly plant, which straddles the border of Detroit and the enclave of Hamtramck. That plant also makes the Opel Ampera, the Chevrolet Impala and the Cadillac ELR, a luxury version of the Volt.

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.